Attenuation of epinephrine-induced dysrhythmias by bradykinin: Role of nitric oxide and prostaglandins

American Journal of Cardiology

Volumn 80, Issue 3 A, 1997, Pages 153A-157A

  Rajani, Vinod ^a   Hussain, Yasser ^a   Bolla, Bhupinder S ^a   De Guzman, Felix Q ^a   Montiague, Raul R ^a   Igić, Rajko ^a   Rabito, Sara F ^a  

^a Jr Hospital of Cook County   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BRADYKININ; BRADYKININ[8 LEUCINE 9 DEARGININE]; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDRALAZINE; ICATIBANT; INDOMETACIN; LOSARTAN; N(G) NITROARGININE; NITRIC OXIDE; PROSTAGLANDIN; TRIMETAPHAN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MECHANISM; ELECTROCARDIOGRAPHY MONITORING; HEART ARRHYTHMIA; HEART PROTECTION; HEART VENTRICLE EXTRASYSTOLE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT; VASODILATATION;

EID: 0030765190     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00472-4     Document Type: Conference Paper

References (26)

1. Katz RL, Bigger JT. Cardiac arrhythmias during anesthesia and operation. Anesthesiology. 33:1970;193-213.
2. Atlee JL, Bosnjak ZJ. Mechanism for cardiac dysrhythmias during anesthesia. Anesthesiology. 72:1990;347-374.
3. Kuner J, Enescu V, Utsu F, Boszormenyi E, Bernstein H, Corday E. Cardiac arrhythmias during anesthesia. Dis Chest. 52:1967;580-587.
4. Bertrand CA, Steiner NV, Jameson AG, Lopez M. Disturbances of cardiac rhythm during anesthesia and surgery. JAMA. 216:1971;1615-1617.
5. Pace NL, Ohmura A, Wong KC. Epinephrine-induced arrhythmias. Anesth Analg. 58:1979;401-404.
6. Katz RL, Katz GJ. Surgical infiltration of pressor drugs and their interaction with volatile anaesthetics. Br J Anaesth. 38:1966;712-718.
7. Katz RL, Epstein RA. The interaction of anesthetic agents and adrenergic drugs to produce arrhythmias. Anesthesiology. 29:1968;763-784.
8. Schölkens BA, Linz W, Martorana PA. Experimental cardiovascular benefits of angiotensin-converting enzyme inhibitors: beyond blood pressure reduction. J Cardiovasc Pharmacol. 18:1991;S26-S30.
9. Liu Y-H, Yang X-P, Sharov VG, Sigmon DH, Sabbah HN, Carretero OA. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats. Hypertension. 27:1996;7-13.
10. Shimada Y, Avkiran M. UAttenuation of reperfusion arrhythmias by selective inhibition of angiotensin-converting enzyme/kininase II in the ischemic zone: mediated by endogenous bradykinin? J Cardiovasc Pharmacol. 27:1996;428-438.
11. van Wij Gaarden J, Tio RA, van Gilst WH, de Graeff PA, de Langen CDJ, Wesseling H. Basic pharmacology of ACE-inhibitors with respect to ischaemic heart disease: prostaglandins and bradykinin. Eur Heart J. 11:1990;84-93.
12. Massoudy P, Becker BF, Gerlach E. Nitric oxide accounts for postischemic cardioprotection resulting from angiotensin-converting enzyme inhibition: indirect evidence for a radical scavenger effect in isolated guinea pig heart. J Cardiovasc Pharmacol. 25:1995;440-447.
13. Pabla R, Curtis MJ. Effects of NO modulation on cardiac arrhythmias in the rat isolated heart. Circ Res. 77:1995;984-992.
14. Schrör K. Role of prostaglandins in the cardiovascular effects of bradykinin and angiotensin-converting enzyme inhibitors. J Cardiovasc Pharmacol. 20:1992;S68-S73.
15. Sun W, Wainwright CL. The potential antyarrhythmic effects of exogenous and endogenous bradykinin in the ischaemic rat heart in vivo. Coron Artery Dis. 5:1994;541-550.
16. Vegh A, Szekeres L, Parratt JR. Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia-induced arrhythmias in anesthetized dogs. Br J Pharmacol. 104:1991;294-295.
17. Tobe TJM, de Langen CDJ, Tio RA, Bel KJ, Mook PH, Wesseling H. Effects of bradykinin on inducible sustained ventricular tachycardia two weeks after myocardial infarction in pigs. J Cardiovasc Pharmacol. 17:1991;701-706.
18. 1 receptor. Br J Pharmacol. 108:1993;318-322.
19. Minshall DR, Yelamanchi VP, Djokovic A, Miletich DJ, Erdös EG, Rabito SF, Vogel SM. Importance of the sympathetic innervation in the positive inotropic effects of bradykinin and ramiprilat. Circ Res. 74:1994;441-447.
20. Seyedi N, Levi R. Bradykinin facilitates norepinephrine exocytosis from cardiac sympathetic nerve endings (Abstr). FASEB J. 10:1996;A695.
21. 2-receptor-mediated stimulation of exocytotic norepinephrine release from cardiac sympathetic neurons (Abstr). Circulation. 92:1995;I317.
22. Vaz-da-Silva M, Magina S, Domingues-Costa A, Moura D, Guimaraes S. The role of the endocardium in the facilitatory effect of bradykinin on electrically induced release of noradrenaline in rat cardiac ventricle. Br J Pharmacol. 118:1996;364-368.
23. Saito K, Gutkind JS, Saavedra JM. Angiotensin II binding sites in the conduction system of rat hearts. Am J Physiol. 253:1987;H1618-H1622.
24. Allen IS, Cohen NM, Dhallan RS, Gaa ST, Lederer WJ, Rogers TB. Angiotensin II increases spontaneous contractile frequency and stimulates calcium current in cultured neonatal rat heart myocytes: insights into the underlying biochemical mechanisms. Circ Res. 62:1988;524-534.
25. Kass RS, Blair ML. Effects of angiotensin II on membrane current in cardiac Purkinje fibers. J Mol Cell Cardiol. 13:1981;797-809.
26. 2+ current in sinoatrial node cells of rabbits. Am J Physiol. 268:1995;H1053-H1060.